Interferon-gamma in mobilized stem cells: A possible prognostic marker in early post-transplant management in multiple myeloma.
CONCLUSION: IFN-γ in PHSC seems to be an important biomarker of loss of response in MM, suggesting a role in early post-transplant therapeutic management.
PMID: 29602156 [PubMed - as supplied by publisher]
Source: Cytokine - Category: Molecular Biology Authors: Martins LNGF, Morita AA, Broto GE, Takakura É, da Silva SS, Tomiotto-Pellissier F, Conchon-Costa I, Pavanelli WR, Panis C, Barbosa DS Tags: Cytokine Source Type: research
More News: Molecular Biology | Myeloma | Statistics | Stem Cell Therapy | Stem Cells | Study | Transplants